Tirzepatide News | Live Feed & Top Stories

Tirzepatide

The Irish Independent21:51Tariffs Business (US) Pharma

Forbes11:08Tariffs Business (US) Pharma

Pharmaceutical Technology07:01Obesity Novo Nordisk Medicare

pharmaphorum06:35Obesity Novo Nordisk Medicare

Valley Independent Sentinel08:30Eli Lilly Connecticut Pharma

National Law Review18:26Eli Lilly Connecticut Pharma

The Economic Times15:29Ozempic India Global Health

The Economic Times15:32Ozempic India Global Health

Pharmacy Times10:41Obesity Global Health Mounjaro

Pharmaceutical Technology03:58Obesity Global Health Mounjaro

News-Medical.Net22:02Obesity

pharmaphorum08:56Obesity

Tyla09:05Meghan Trainor Mounjaro Music

Tyla07:03Meghan Trainor Mounjaro Music

MobiHealthNews10:45Eli Lilly Mounjaro Health

pharmaphorum07:09Eli Lilly Mounjaro Health

Financial Mail08:57Mounjaro Eli Lilly Pharma

Yahoo! US18:01Mounjaro Eli Lilly Pharma

Pharmacy Times13:02Health Pharma The Lancet

Pharmacy Times17:17Health Pharma The Lancet

Latest News

In the last 5 minutes

News-Medical.Net22:22

In the last 6 hours

Yahoo! UK & Ireland18:06

ABC7 / KABC-TV16:35

In the last 8 hours

The Independent15:38

Earlier today

MailOnline13:26

People11:30

Valley Independent Sentinel08:30

PR Newswire (Press Release)07:33

Yesterday

Scrip Pharma Intelligence17:59 10-Apr-25

Pharmacy Times15:17 10-Apr-25

UNILAD15:12 10-Apr-25

The Tribune, California14:56 10-Apr-25

MailOnline13:42 10-Apr-25

FoodNavigator.com12:04 10-Apr-25

The House of Commons Library blog11:50 10-Apr-25

Management in Practice11:50 10-Apr-25

The Fresno Bee11:48 10-Apr-25

Science News Online11:03 10-Apr-25

MailOnline05:51 10-Apr-25

i News02:18 10-Apr-25

In the last 7 days

News-Medical.Net22:02 9-Apr-25

The Mirror18:57 9-Apr-25

Medpage Today14:27 9-Apr-25

Pharmacy Times13:02 9-Apr-25

MailOnline13:01 9-Apr-25

Business Weekly09:38 9-Apr-25

PR Newswire (Press Release)08:02 9-Apr-25

ThePrint00:09 9-Apr-25

American Journal of Managed Care16:24 8-Apr-25

The Economic Times15:29 8-Apr-25

Health Magazine12:53 8-Apr-25

The Economic Times12:46 8-Apr-25

Zacks11:18 8-Apr-25

GlobeNewswire (Press Release)08:32 8-Apr-25

The State, South Carolina20:47 7-Apr-25

BioWorld17:02 7-Apr-25

The Nittany Turkey (Weblog)12:44 7-Apr-25

Pharmacy Times10:41 7-Apr-25

Pharmaceutical Technology07:01 7-Apr-25

pharmaphorum06:35 7-Apr-25

Knowridge Science Report05:59 7-Apr-25

The Irish Independent21:51 6-Apr-25

The Economic Times15:32 6-Apr-25

PRWeb (Press Release)14:03 5-Apr-25

Forbes13:35 5-Apr-25

Medpage Today11:35 5-Apr-25

Medpage Today17:36 4-Apr-25

American Journal of Managed Care13:55 4-Apr-25

PR Newswire (Press Release)11:42 4-Apr-25

HealthDay11:21 4-Apr-25

Forbes11:08 4-Apr-25

Korea Biomedical Review06:22 4-Apr-25

In the last month

Law36020:50 3-Apr-25

Mercury News18:04 3-Apr-25

MobiHealthNews10:45 3-Apr-25

Tyla09:05 3-Apr-25

Tyla07:03 3-Apr-25

National Law Review18:26 2-Apr-25

The Motley Fool18:22 2-Apr-25

Pharmacy Times17:17 2-Apr-25

Journal of American Medical Associations11:50 2-Apr-25

Pharmaceutical Technology11:45 2-Apr-25

GlobeNewswire (Press Release)09:01 2-Apr-25

Financial Mail08:57 2-Apr-25

British Medical Journal08:23 2-Apr-25

GPonline.com05:42 2-Apr-25

Pharmaceutical Technology03:58 2-Apr-25

Hindustan Times20:51 1-Apr-25

Knowridge Science Report20:26 1-Apr-25

The Motley Fool19:18 1-Apr-25

UnHerd19:09 1-Apr-25

Yahoo! US18:01 1-Apr-25

The Motley Fool16:24 1-Apr-25

ENDPOINTS15:31 1-Apr-25

Medpage Today15:06 1-Apr-25

Wall Street Pit14:44 1-Apr-25

Newswise (Press Release)13:41 1-Apr-25

Fox News13:05 1-Apr-25

The Hindu Business Line12:23 1-Apr-25

The Independent11:30 1-Apr-25

Miami Herald11:24 1-Apr-25

Quartz11:17 1-Apr-25

Invezz10:57 1-Apr-25

GlobeNewswire (Press Release)07:04 1-Apr-25

The Financial Express06:58 1-Apr-25

The Financial Express06:42 1-Apr-25

The Motley Fool05:44 1-Apr-25

Tyla05:40 1-Apr-25

Bloomberg Law05:02 1-Apr-25

Music-News.com04:19 1-Apr-25

News-Medical.Net23:16 31-Mar-25

People23:14 31-Mar-25

Medpage Today17:03 31-Mar-25

Quartz13:54 31-Mar-25

The Nittany Turkey (Weblog)12:53 31-Mar-25

Scrip Pharma Intelligence11:18 31-Mar-25

Business Wire (Press Release)09:26 31-Mar-25

GlobeNewswire (Press Release)08:39 31-Mar-25

PR Newswire (Press Release)08:36 31-Mar-25

PR Newswire (Press Release)07:37 31-Mar-25

Futurism12:41 30-Mar-25

Knowridge Science Report06:31 30-Mar-25

The Motley Fool03:21 30-Mar-25

Eurasia Review19:13 29-Mar-25

Pharmacy Times14:12 28-Mar-25

Pharmaceutical Technology12:26 28-Mar-25

pharmaphorum07:09 28-Mar-25

Women's Health06:18 28-Mar-25

Wellbeing News04:06 28-Mar-25

The Motley Fool03:50 28-Mar-25

The Economic Times00:18 28-Mar-25

view more headlines

11 Apr 22:22

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

쮸떴눈첵

Tirzepatide

Latest News

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories